Tuesday, 15 May 2012
Cerebrolysin For Alzhiemer’s Disease Treatment
Alzhiemer’s disease is one of the most debilitating and most popular form of mental decline. As per the estimates nearly 25-30 million of the people worldwide are affected by this debilitating condition. While alzhiemer’s disease is known to occur mostly in the elderly population of over 60 years of age, now days given the hectic lifestyle, faulty diets and polluted environment it can even occur in individuals as young as 40 years of age. While most alzheimer’s disease treatments only target the symptoms, Cerebrolysin is an innovative drug that is designed to target the cause for proper alzhiemer’s disease treatment.
However, since initial symptoms are very mild and of generic nature like general forgetfulness people tend to ignore these symptoms, thus making this disease remain undiagnosed for a long time. While there are innumerable studies and theories regarding the cause of this serious mental decline, the exact cause still remains unknown and obscure.
However, the main and popular theory put forward by the scientists is that the disease is caused due to some mal functioning in the neurotransmitters of the brain and the way brain cells communicate with each other resulting in progressive mental decline which is fatal and irreversible.
In such a scenario, cerebrolysin offers a ray of hope for those suffering with this debilitating condition and those attached with these victims of alzhiemer’s disease. Cerebrolysin works to improve the function and the quantity of neurons and brain transmitters by blocking exitocins and decreasing the rate at which brain cells die. Since exitocins are cited to be the main reason behind the occurrence of alzhiemer’s disease and other mental and bodily decline in most individuals, by blocking the action of these exitocins, cerebrolysin prove to be an excellent anti ageing supplement and alzhiemer’s disease treatment .
Since at the later stage of alzhiemer’s disease, the disease not only affects and fails the sufferer’s ability to recall facts but also impairs the entire mental and bodily functions rendering a person in an almost vegetative condition. As per a recent finding through the post porten reports of alzhiemer’s disease victims, it has been found that those with Alzheimer disease had a lower level of the brain neurotransmitter, Acetylcholine.
Since acetylcholine is lowered due to the action of exitocins, cerebrolysin by breaking the action of exitocins help treat alzhiemer’s disease and any other form of mental decline. Not only does cerebrolysin prevent damage, it also appears to help support and maintain neurons including: serotonin, choline (related to Acetylcholine) and noradrenaline. Cerebrolysin treatment involves injecting a 5ml ampoule either in the muscle or in the vein each day for 5 days, then repeated for a period of 4 weeks.